Foods to Avoid
Food for Breast Cancer
Pertuzumab: Trade name Perjeta. A monoclonal antibody that has been approved to treat metastatic HER/neu overexpressing (HER2+) breast cancer in combination with other drugs.
Long‐Term Survival of De Novo Stage IV Human Epidermal Growth Receptor 2 (HER2) Positive Breast Cancers Treated with HER2‐Targeted Therapy
Pertuzumab in HER2-positive breast cancer: a guide to its use
Role of Anti-HER-2 Therapies in the Neo-Adjuvant Setting: Is Complete Pathological Response a Solid Surrogate?
Pertuzumab: new hope for patients with HER2-positive breast cancer
What is the current standard of care for anti-HER2 neoadjuvant therapy in breast cancer?
Pertuzumab Monotherapy After Trastuzumab-Based Treatment and Subsequent Reintroduction of Trastuzumab: Activity and Tolerability in Patients With Advanced Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer
Cardiovascular side effects of cancer therapies: a position statement from the Heart Failure Association of the European Society of Cardiology
Targeting Signal Transduction Pathways in Metastatic Breast Cancer: A Comprehensive Review
Breast cancer resources
Selected supplements and vitamins
Make a donation